CIBC World Market
TAK icon

CIBC World Market’s Takeda Pharmaceutical TAK Stock Holding History

CIBC World Market’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
16,880
+2,520
+18% +$41.7K ﹤0.01% 1403
2026
Q1 		$266K Buy
14,360
+3,525
+33% +$61.9K ﹤0.01% 1311
2025
Q4 		$169K Buy
+10,835
New +$155K ﹤0.01% 1387

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

CIBC World Market's TAK Position: Q2 2026 in Review

CIBC World Market increased its Takeda Pharmaceutical (TAK) stake by 18% in Q2 2026, buying an estimated $41.7K and bringing the position to 16,880 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

CIBC World Market first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • CIBC World Market held 16,880 shares of Takeda Pharmaceutical worth $271K as of Q2 2026.
  • CIBC World Market bought 2,520 Takeda Pharmaceutical shares in Q2 2026, an estimated $41.7K.
  • Takeda Pharmaceutical made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1403 holding.
  • CIBC World Market first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.